Skip to main content
. 2013 Jul 3;2(3-4):153–331. doi: 10.1159/000343846
Total n = 3202a (100)
CP-A n = 1968 (61.5)
CP-B n = 666 (20.8)
All DR All DR All DR
AEs, %b
 All grades 85.3 66.0 84.0 68.5 88.6 64.4
 Grade 3/4 31.7 23.5 32.4 25.6 31.5 21.9
 SAEs 43.3 9.3 36.0 8.8 60.4 14.1
AE rate (event per patient-year)b
 Any AE 1.61 1.24 1.44 1.17 2.14 1.55
 Diarrhea 0.58 0.51 0.54 0.48 0.71 0.62
 Hand-foot skin reaction 0.51 0.50 0.55 0.54 0.42 0.41
 Fatigue 0.45 0.29 0.38 0.27 0.62 0.34
Discontinuation due to AEs, %b 31.4 28.9 40.1
Daily dose, median, mgd 688.0 677.0 741.5
Treatment duration, median, weeksd 15.0 17.6 9.9
a

Includes CP-C, 74 pts; not evaluable, 493 pts

b

Treatment-emergent

c

Calculated based on 365.25 days per year

d

Pts with dosing data.